Search

The Ellume COVID-19 home test from Ellume Health (Brisbane, Aus) became the first COVID-19 diagnostic tool authorized for home use by the United States FDA in December 2020. This early pandemic success was built on over ten years of work on the Ellume influenza home test. Ellume overcame critical technology challenges during the development of their influenza test. In addition, it faced a recall of its COVID-19 home test in 2021 due to false positive results. While Ellume initially persevered through the recall and restarted sales in the United States, the combination of the recall and the wide availability of competitors' low-cost over the counter tests in the United States led to Ellume entering voluntary administration in September 2022. This paper traces the history of Ellume and how 10 years of experience with a home influenza test allowed the company to quickly develop the Ellume COVID-19 home test. We will also provide to diagnostic developers the key strategies employed by Ellume to succeed while highlighting the pitfalls that have challenged the company's business success. [ABSTRACT FROM AUTHOR]

In this paper, CN-DPAwas prepared as an effective colorimetric and fluorescent probe for copper ions (Cu2) in aqueous solution. It exhibits good sensitivity and selectivity for Cu2ꋷ other metal ions both in aqueous solution and on a simple colorimetric paper-made test kit. Upon addition of Cu2, a remarkable color change from purple to colorless was easily observed by the naked eye, and a fluorescence quenching was also determined. Furthermore, CN-DPAcan be used to quantitatively detect Cu2. The linear range was 0–5 μM determined by absorption spectrometry. All these selective and sensitive results indicate that CN-DPAcould meet the selective requirements for biomedical and environmental application and be sensitive enough to detect Cu2 environmental water samples, even in drinking water, which has a limit of 20 μM defined by the U.S. Environmental Protection Agency. [ABSTRACT FROM AUTHOR]

There are over 450 000 sites contaminated by chemicals in the US. This large number of contaminated sites and the speed of subsurface migration of chemicals pose considerable risk to nearby residences and commercial buildings. The high costs for monitoring around these sites stem from the labor involved in placing and replacing the passive sorbent vapor samplers and the resultant laboratory analysis. This monitoring produces sparse data sets that do not track temporal changes well. To substantially reduce costs and better track exposures, less costly, unattended systems for monitoring soil gases and vapor intrusion into homes and businesses are desirable to aid in the remediation of contaminated sites. This paper describes progress toward the development of an inexpensive system specifically for monitoring vapor intrusion; the system can operate repeatedly without user intervention with low detection limits (1 × 10−9, or 1 part-per-billion). Targeted analytes include chlorinated hydrocarbons (dichloroethylene, trichloroethane, trichloroethylene, and perchloroethylene) and benzene. The system consists of a trap-and-purge preconcentrator for vapor collection in conjunction with a compact gas chromatography instrument to separate individual compounds. Chemical detection is accomplished with an array of chemicapacitors and a metal-oxide semiconductor combustibles sensor. Both the preconcentrator and the chromatography column are resistively heated. All components are compatible with ambient air, which serves as the carrier gas for the gas chromatography and detectors. [ABSTRACT FROM AUTHOR]